Disease | hepatitis c |
Symptom | C0004364|autoimmune diseases |
Sentences | 1 |
PubMedID- 25195983 | Before determining the safety of anti-tnf drugs in the treatment of autoimmune diseases in patients with hepatitis c infection, studies with large homogeneous patient groups must be performed, and the exact group of hepatitis c virus infected patients for whom anti-tnf treatment would be deemed safe should be identified. |
Page: 1